Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
180.00
+1.90 (1.07%)
Jun 30, 2026, 4:08 PM HKT
HKG:2637 Revenue
In the year 2025, Fujian Haixi Pharmaceuticals had annual revenue of 582.36M CNY with 24.79% growth.
Revenue
582.36M CNY
Revenue Growth
+24.79%
P/S Ratio
21.86
Revenue / Employee
2.91M CNY
Employees
200
Market Cap
14.17B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 582.36M | 115.68M | 24.79% |
| Dec 31, 2024 | 466.68M | 150.05M | 47.39% |
| Dec 31, 2023 | 316.63M | 104.17M | 49.03% |
| Dec 31, 2022 | 212.47M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition